FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19524411000001100: Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66109301000001114 Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66109401000001118 Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Is a Abiraterone 250mg tablets 120 tablet true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Has AMP Zytiga 250mg tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Has specific active ingredient Abiraterone acetate false Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Has specific active ingredient Abiraterone acetate true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Zytiga 250mg tablets (Janssen-Cilag Ltd) 120 tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start